Sign in

    Ning Jia

    Research Analyst at Century Management

    Ning Jia is an Analyst at Century Management specializing in fundamental research and equity analysis across multiple sectors, with an emphasis on consumer goods, technology, and industrial companies. She has covered notable firms such as Apple, Microsoft, Procter & Gamble, and Caterpillar, achieving a success rate of approximately 68% on her stock recommendations and generating an average excess return of 8% for investors according to TipRanks metrics. Ning began her professional career in 2012, working at boutique investment firms before joining Century Management in 2018, where she has grown her coverage universe and built a reputation for thorough company due diligence. She holds FINRA Series 7 and Series 63 licenses, and her analytical expertise has earned recognition among asset management peers for outperforming sector benchmarks.

    Ning Jia's questions to Vivani Medical (VANI) leadership

    Ning Jia's questions to Vivani Medical (VANI) leadership • Q4 2016

    Question

    Ning Jia from Century Management asked about the competitive threat from eSight, questioning its market overlap with the Argus II for better-sighted patients and the future Orion device. She also inquired about the company's patient outreach strategy, asking if radio was the main channel and why social media wasn't more heavily utilized.

    Answer

    Chairman Dr. Robert Greenberg explained that eSight is a non-reimbursable, low-vision aid that enhances, not restores, vision, making it a complementary technology with no foreseeable market overlap with Argus II or Orion. President and CEO Will McGuire detailed the patient outreach process, confirming radio ads are the primary and most cost-effective channel for generating qualified patient leads, though they also use social media and work with organizations like the Foundation for Fighting Blindness.

    Ask Fintool Equity Research AI